Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2025-05-22
2025-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quick Measure Study for iCare ST500 and iCare IC200
NCT07156630
Icare Tonometry Effects on Keratometry Readings, Topography Readings, and Corneal Staining
NCT03275142
Clinical Validation of iCare IC1000 Tonometer
NCT06748092
Icare Versus Haag-Streit Applanation Tonometer
NCT01159340
iCare HOME2 Clinical Trial
NCT05162989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Measurement of IOP Values
iCare IC1000 measurement
Measurement of intraocular pressure with iCare IC1000
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iCare IC1000 measurement
Measurement of intraocular pressure with iCare IC1000
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Central corneal scarring
3. Microphthalmos
4. Buphthalmos
5. Contact lens use during measurement or hard lenses 24h prior to measurement
6. Dry eyes (clinically significant)
7. Nystagmus
8. Keratoconus
9. Any other corneal or conjunctival pathology or infection relevant to this study
10. Coloboma or other pupil deformation
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icare Finland Oy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clear Vue Laser Eye Center
Lake Worth, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TA032-168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.